Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Mepolizumab for Eosinophil-Associated COPD: Analysis of METREX and METREO.
Journal: International journal of chronic obstructive pulmonary disease
Published: December 09, 2020
Validation of the Summit Lab Score in Predicting Exacerbations of Chronic Obstructive Pulmonary Disease Among Individuals with High Arterial Stiffness.
Journal: International journal of chronic obstructive pulmonary disease
Published: September 05, 2020
Mepolizumab for Eosinophilic Chronic Obstructive Pulmonary Disease.
Journal: The New England journal of medicine
Published: September 13, 2017
A randomized trial of once-daily fluticasone furoate/vilanterol or vilanterol versus placebo to determine effects on arterial stiffness in COPD.
Journal: International journal of chronic obstructive pulmonary disease
Published: February 09, 2017
Long-acting bronchodilators and arterial stiffness in patients with COPD: a comparison of fluticasone furoate/vilanterol with tiotropium.
Journal: Chest
Published: July 25, 2014
Inhaled β-agonist does not modify sympathetic activity in patients with COPD.
Journal: BMC pulmonary medicine
Published: July 20, 2014
Risk of pneumonia with inhaled corticosteroid/long-acting β2 agonist therapy in chronic obstructive pulmonary disease: a cluster analysis.
Journal: International journal of chronic obstructive pulmonary disease
Published: May 24, 2014
Which patients with chronic obstructive pulmonary disease benefit from the addition of an inhaled corticosteroid to their bronchodilator? A cluster analysis.
Journal: BMJ open
Published: April 25, 2013
Showing 1-8 of 8
Last Updated: 09/26/2026